S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
Log in
NASDAQ:TZAC

Tenzing Acquisition Stock Forecast, Price & News

$9.31
+0.12 (+1.31 %)
(As of 01/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.09
Now: $9.31▼
$9.61
50-Day Range
$7.92
MA: $9.41▼
$11.10
52-Week Range
$8.33
Now: $9.31▼
$15.10
Volume45,318 shs
Average Volume46,767 shs
Market Capitalization$47.68 million
P/E RatioN/A
Dividend YieldN/A
Beta0.01
Tenzing Acquisition Corp. does not have significant operations. It intends to acquire, engage in a share exchange, share reconstruction and amalgamation with, purchase all or substantially all of the assets of, enter into contractual arrangements with, or engage in any other similar business combination with one or more businesses or entities primarily operates in India. The company was founded in 2018 and is based in New York, New York.

MarketRank™

Overall MarketRank™

0.33 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorUnclassified
Current SymbolNASDAQ:TZAC
Previous Symbol
CUSIPN/A
CIKN/A
WebN/A
Phone212-710-5220
EmployeesN/A

Debt

Debt-to-Equity Ratio0.28
Current Ratio0.05
Quick Ratio0.05

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash Flow$0.07 per share
Price / Cash Flow143.10
Book Value$0.98 per share
Price / Book9.50

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$620,000.00
Net MarginsN/A
Return on Equity-13.32%
Return on Assets-1.36%

Miscellaneous

Outstanding Shares5,124,000
Market Cap$47.68 million
Next Earnings DateN/A
OptionableNot Optionable
$9.31
+0.12 (+1.31 %)
(As of 01/14/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TZAC News and Ratings via Email

Sign-up to receive the latest news and ratings for TZAC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Tenzing Acquisition (NASDAQ:TZAC) Frequently Asked Questions

What stocks does MarketBeat like better than Tenzing Acquisition?

Wall Street analysts have given Tenzing Acquisition a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Tenzing Acquisition wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Tenzing Acquisition's key competitors?

Some companies that are related to Tenzing Acquisition include Infinity Pharmaceuticals (INFI), AcelRx Pharmaceuticals (ACRX), Abeona Therapeutics (ABEO), DiaMedica Therapeutics (DMAC), ProPhase Labs (PRPH), GlycoMimetics (GLYC), Aquestive Therapeutics (AQST), OncoSec Medical (ONCS), Sierra Oncology (SRRA), Lumos Pharma (LUMO), NeuBase Therapeutics (NBSE), scPharmaceuticals (SCPH), Taiwan Liposome (TLC), FS Development (FSDC) and Eyenovia (EYEN).
View all of TZAC's competitors.

Who are Tenzing Acquisition's key executives?

Tenzing Acquisition's management team includes the following people:
  • Mr. Rahul Nayar, CEO & Director (Age 51)
  • Mr. Gonzalo Cordova CFA, Chief Financial Officer (Age 65)

What is Tenzing Acquisition's stock symbol?

Tenzing Acquisition trades on the NASDAQ under the ticker symbol "TZAC."

How do I buy shares of Tenzing Acquisition?

Shares of TZAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tenzing Acquisition's stock price today?

One share of TZAC stock can currently be purchased for approximately $9.31.

How big of a company is Tenzing Acquisition?

Tenzing Acquisition has a market capitalization of $47.68 million.

How can I contact Tenzing Acquisition?

Tenzing Acquisition's mailing address is 250 WEST 55TH STREET, NEW YORK NY, 10019. The company can be reached via phone at 212-710-5220.

This page was last updated on 1/15/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.